ERYSENG PARVO in Biological Products

DESCRIPTION:

Inactivated Vaccine

​

COMPOSITION:

Inactivated porcine parvovirus, strain NADL-2, RP* > 1.15 *

Inactivated Erysipelothrix rhusiopathiae, strain R32E11, ELISA > 3.34 log 2 IE50% ** * RP - relative potency (ELISA). ** IE50% - Inhibition ELISA 50%.

​

INDICATIONS:

For the active immunisation of pigs for the protection of progeny against transplacental infection caused by Porcine Parvovirus.

For the active immunisation of pigs to prevent clinical signs and lesions caused by Erysipelas, serotype 1 and serotype 2.

 

SIDE EFFECTS:

 Slight in­flammation at the injection site, that lasts for less than 48 hours in most cases. A very slight and transient increase in body temperature during the ‑First 6 hours after injection, which spontaneously resolves within 24 hours without compromising animal health status. If you notice any serious effects or other effects not mentioned in this package leafl­et, please inform your veterinary surgeon.

​

ADMINISTRATION ROUTE:

Intramuscular use. Administer one dose of 2 ml by intramuscular injection in the neck muscles

 

Basic vaccination:

Pigs from 6 months of age which have not been previously vaccinated with the product should be given two injections with an interval of 3-4 weeks. The second injection should be administered 3-4 weeks before mating.

 

Revaccination:

A single injection should be given 2-3 weeks prior to each subsequent mating (approximately every 6 months).

Allow the vaccine to reach room temperature (15 - 25 ºC) before administration.

Shake well before use.

​

WITHDRAWAL PERIOD:

Zero days.

​

SPECIAL STORAGE PRECAUTIONS:

Store and transport refrigerated (2 ºC - 8 ºC). Do not freeze. Protect from light.

​

PACKAGING:

Cardboard box with 1 glass vial of 25 doses (50 ml).